Radomski Michal, Pai Reetesh K, Shuai Yongli, Ramalingam Lekshmi, Jones Heather, Holtzman Matthew P, Ahrendt Steven A, Pingpank James F, Zeh Herbert J, Bartlett David L, Choudry Haroon A
Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, USA.
Department of Pathology, University of Pittsburgh, Pittsburgh, USA.
Ann Surg Oncol. 2016 Dec;23(13):4338-4343. doi: 10.1245/s10434-016-5412-z. Epub 2016 Jul 11.
The impact of histopathologic features on oncologic outcomes for patients with peritoneal metastases from goblet cell carcinoid (GCC) undergoing multimodality therapy, including cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC), is unknown.
This study prospectively analyzed 43 patients with GCC undergoing CRS-HIPEC between 2005 and 2013. Pathology slides were re-reviewed to classify GCC into histologic subtypes according to the Tang classification. Kaplan-Meier survival curves and multivariate Cox-regression models identified prognostic factors affecting oncologic outcomes.
The 43 patients in this study underwent 50 CRS-HIPEC procedures for peritoneal metastases from GCC, and the majority received neoadjuvant and/or adjuvant systemic chemotherapy. The GCC demonstrated an aggressive phenotype with frequent lymph node and peritoneal metastases without systemic dissemination. The majority of the patients had Tang B GCC. The estimated median overall survival times after surgery for the patients with Tang A, B, and C GCC were respectively 59, 22, and 13 months. In a multivariate Cox-regression analysis, poor survival was associated with patients who had Tang B or C GCC, those undergoing incomplete macroscopic resection, and those with symptoms at the time of CRS-HIPEC. The patients with Tang A GCC demonstrated oncologic outcomes similar to those with intermediate-grade (American Joint Committee on Cancer [AJCC] grade 2) disseminated mucinous appendiceal neoplasms, whereas the patients with Tang B and C GCC demonstrated survival rates similar to or worse than those with high-grade (AJCC grade 3) disseminated mucinous appendiceal neoplasms.
Tang classification is an independent prognostic factor for poor survival after multimodality therapy for GCC. Patients with Tang C GCC demonstrate limited survival and are not ideal candidates for a surgical approach.
对于接受多模式治疗(包括细胞减灭术联合腹腔热灌注化疗[CRS-HIPEC])的杯状细胞类癌(GCC)腹膜转移患者,组织病理学特征对肿瘤学结局的影响尚不清楚。
本研究前瞻性分析了2005年至2013年间43例接受CRS-HIPEC的GCC患者。重新审查病理切片,根据Tang分类将GCC分为组织学亚型。采用Kaplan-Meier生存曲线和多变量Cox回归模型确定影响肿瘤学结局的预后因素。
本研究中的43例患者因GCC腹膜转移接受了50次CRS-HIPEC手术,大多数患者接受了新辅助和/或辅助全身化疗。GCC表现出侵袭性表型,常有淋巴结和腹膜转移但无全身播散。大多数患者为Tang B型GCC。Tang A、B和C型GCC患者术后的估计中位总生存时间分别为59个月、22个月和13个月。在多变量Cox回归分析中,生存不佳与Tang B或C型GCC患者、接受肉眼不完全切除的患者以及CRS-HIPEC时出现症状的患者相关。Tang A型GCC患者的肿瘤学结局与中级别(美国癌症联合委员会[AJCC]2级)播散性黏液性阑尾肿瘤患者相似,而Tang B和C型GCC患者的生存率与高级别(AJCC 3级)播散性黏液性阑尾肿瘤患者相似或更差。
Tang分类是GCC多模式治疗后生存不佳的独立预后因素。Tang C型GCC患者的生存期有限,不是手术治疗的理想候选者。